Sodium Sources and Sodium Intake in a Representative Sample of Spanish Children
Launched by UNIVERSIDAD COMPLUTENSE DE MADRID · Mar 13, 2018
Trial Information
Current as of November 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is observational and cross-sectional, meaning researchers will observe and measure things as they coexist in real life, not test a new treatment. It aims to learn how much salt Spanish schoolchildren aged 7–11 eat and how this relates to body weight, blood pressure, and overall health. To estimate salt intake, they will use a urine test collected over 24 hours and three days of dietary records, along with simple health measurements like height, weight, and body fat. The goal is to determine average salt intake, identify main food sources of sodium, and provide data to support efforts to reduce salt in kids’ diets.
Eligible children are those aged 7–11 who attend school in Spain and can participate with parental consent. Exclusion rules include having certain metabolic or chronic illnesses, taking medicines that could affect blood pressure or sodium levels, or not being in school on measurement days. About 400 children from different regions are expected to join. Participants will provide a 24-hour urine sample, complete dietary records, and undergo basic measurements; the study does not involve a new drug or device, and results may help create reference data and inform public health campaigns to lower salt intake in children.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 7 and 11 years old
- Exclusion Criteria:
- • Those who have any clinical problem, which may modify the results of the analysis: metabolic or chronic diseases (liver, kidney, diabetes, hypothesis or hyperkalemia), pharmacological treatment during the 3 months prior to the study with corticosteroids, insulin, diuretics or other drugs that may modify blood pressure figures, surgery or serious infectious diseases in the previous 6 months.
- • Those who were not in the school when the measures were taken.
About Universidad Complutense De Madrid
The Universidad Complutense de Madrid (UCM) is a prestigious academic institution renowned for its commitment to research and innovation in various fields, including health sciences. As a prominent sponsor of clinical trials, UCM leverages its extensive resources and expertise to advance medical knowledge and improve patient outcomes. The university fosters collaboration among researchers, clinicians, and industry partners, ensuring the highest standards of ethics and scientific rigor in its clinical research initiatives. UCM's dedication to education and research excellence positions it as a leader in the development of new therapeutic interventions and health solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, Spain
Patients applied
Trial Officials
Rosa M Ortega Anta, Full Prof.
Principal Investigator
Universidad Complutense de Madrid
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials